Astec Lifesciences Complete Financial Statements
12 Years of Data
2026 - 2015
In FY2026, Astec Lifesciences (ASTEC) reported revenue ₹161 Cr, net profit ₹-8 Cr and EPS ₹-3.48, with a net profit margin of -5.0% and ROE of -2.0%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore Astec Lifesciences intrinsic worth to estimate fundamental worth using multiple valuation models.
Complete Financial Data Export
Profitability Ratios
Net Profit Margin
-4.97%
2026 data
EBITDA Margin
7.45%
2026 data
Operating Margin
6.00%
2026 data
Return on Assets
-0.85%
2026 data
Return on Equity
-2.05%
2026 data
Balance Sheet Ratios
Current Ratio
8.69
2026 data
Equity Ratio
41.51%
2026 data
Asset Turnover
0.17
2026 data
ASTEC Revenue, Net Profit & EBITDA — Year-on-Year Growth
ASTEC YoY (Mar 2025 vs Mar 2026) — revenue +34.2%, net profit +50.0%, EBITDA +100.0%, expenses +31.6%. Review ASTEC price earnings ratio to evaluate earnings-based valuation against sector peers.
Revenue Growth
+34.2%
Year-over-Year
Net Profit Growth
+50.0%
Year-over-Year
EBITDA Growth
+100.0%
Year-over-Year
Expense Growth
+31.6%
Year-over-Year
Assets Growth
+6.9%
Year-over-Year
Equity Growth
+66.4%
Year-over-Year
Operating Cash Flow Growth
-180.0%
Year-over-Year
Investing Cash Flow Growth
+88.9%
Year-over-Year
Financing Cash Flow Growth
-80.8%
Year-over-Year
ASTEC Income Statement — Revenue, EBITDA & Net Profit
Astec Lifesciences revenue ₹161 Cr, EBITDA ₹12 Cr, net profit ₹-8 Cr, EPS ₹-3.48 (2026) — net profit margin -5.0%. For live price, earnings ratios and company overview, see Astec Lifesciences share price chart.
Periods
₹ Crores
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Mar 2017 | Jun 2017 | Dec 2017 | Sept 2016 | Mar 2016 | Jun 2016 | Dec 2016 | Sept 2015 | Mar 2015 | Jun 2015 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 161 | 75 | 120 | 92 | 126 | 101 | 156 | 70 | 96 | 112 | 130 | 145 | 52 | 204 | 279 | 187 | 121 | 104 | 174 | 130 | 175 | 157 | 186 | 113 | 119 | 142 | 140 | 78 | 129 | 115 | 130 | 66 | 123 | 98 | 87 | 68 | 80 | 86 | 85 | 71 | 62 | 68 | 99 | 60 | 31 |
| Expenses | 150 | 80 | 114 | 102 | 123 | 118 | 141 | 116 | 100 | 114 | 122 | 140 | 69 | 167 | 207 | 159 | 105 | 82 | 134 | 104 | 131 | 126 | 138 | 84 | 100 | 125 | 111 | 71 | 104 | 89 | 97 | 56 | 98 | 81 | 76 | 60 | 61 | 64 | 69 | 59 | 53 | 62 | 91 | 47 | 39 |
| EBITDA | 12 | -6 | 6 | -11 | 3 | -18 | 15 | -45 | -4 | -2 | 8 | 5 | -17 | 37 | 72 | 28 | 16 | 22 | 40 | 26 | 45 | 31 | 48 | 30 | 19 | 17 | 29 | 7 | 25 | 25 | 33 | 9 | 24 | 16 | 11 | 9 | 19 | 22 | 16 | 12 | 10 | 6 | 8 | 12 | -8 |
| Operating Profit Margin % | 6.00% | -9.00% | 5.00% | -12.00% | 2.00% | -20.00% | 8.00% | -67.00% | -6.00% | -3.00% | 4.00% | 2.00% | -36.00% | 17.00% | 24.00% | 14.00% | 10.00% | 21.00% | 22.00% | 19.00% | 25.00% | 19.00% | 24.00% | 25.00% | 13.00% | 11.00% | 17.00% | 8.00% | 17.00% | 21.00% | 24.00% | 13.00% | 18.00% | 15.00% | 12.00% | 9.00% | 18.00% | 25.00% | 12.00% | 16.00% | 14.00% | 7.00% | 2.00% | 20.00% | -26.00% |
| Depreciation | 12 | 10 | 12 | 12 | 11 | 12 | 9 | 9 | 11 | 9 | 8 | 9 | 9 | 8 | 11 | 9 | 9 | 8 | 7 | 7 | 9 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 6 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 2 | 3 | 1 | 3 | 2 |
| Interest | 8 | 8 | 10 | 11 | 7 | 9 | 7 | 7 | 10 | 6 | 6 | 7 | 6 | 5 | 3 | 4 | 6 | 2 | 1 | 2 | 3 | 1 | 2 | 2 | 1 | 4 | 3 | 4 | 3 | 3 | 2 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit Before Tax | -8 | -24 | -16 | -33 | -16 | -39 | -1 | -62 | -25 | -18 | -6 | -11 | -32 | 25 | 58 | 15 | 1 | 12 | 32 | 17 | 33 | 24 | 40 | 22 | 11 | 8 | 20 | -2 | 16 | 18 | 27 | 3 | 15 | 10 | 4 | 6 | 13 | 15 | 15 | 5 | 5 | 2 | 4 | 7 | -11 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -22 | 15 | -4 | -1 | -3 | -8 | 6 | 15 | 4 | 0 | 3 | 8 | 5 | 9 | 6 | 9 | 6 | 4 | 3 | 8 | -1 | 3 | 6 | 10 | 1 | 5 | 3 | 1 | 2 | 6 | 4 | 9 | 1 | 4 | 0 | 1 | 2 | -3 |
| Net Profit | -8 | -24 | -16 | -33 | -16 | -39 | -1 | -40 | -40 | -13 | -5 | -8 | -24 | 18 | 43 | 11 | 1 | 9 | 24 | 13 | 25 | 18 | 31 | 16 | 7 | 5 | 13 | -1 | 12 | 12 | 17 | 2 | 10 | 7 | 4 | 4 | 7 | 11 | 6 | 4 | 1 | 2 | 3 | 5 | -8 |
| Earnings Per Share (₹) | -3.48 | -11.35 | -8.20 | -16.85 | -7.04 | -19.66 | -0.50 | -20.26 | -20.59 | -6.85 | -2.54 | -4.18 | -12.41 | 9.34 | 21.97 | 5.82 | 0.43 | 4.63 | 12.24 | 6.63 | 12.63 | 9.12 | 15.94 | 8.27 | 3.61 | 2.70 | 6.50 | -0.57 | 6.22 | 5.92 | 8.78 | 0.08 | 5.10 | 3.44 | 1.77 | 2.04 | 3.67 | 5.74 | 2.88 | 1.93 | 0.36 | 1.05 | 1.74 | 2.66 | -4.03 |
ASTEC Balance Sheet — Assets, Liabilities & Shareholders' Equity
ASTEC total assets ₹942 Cr, total equity ₹391 Cr, total liabilities ₹ Cr (2026) — ROE -2.0%.
Years
Annual Data
₹ Crores
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 942 | 881 | 975 | 979 | 897 | 678 | 572 | 461 | 413 | 334 | 330 | 362 |
| Current Assets | 443 | 341 | 399 | 499 | 516 | 330 | 332 | 249 | 232 | 198 | 191 | 204 |
| Fixed Assets | 479 | 499 | 386 | 319 | 340 | 213 | 194 | 167 | 115 | 103 | 95 | 133 |
| Capital Work in Progress | 0 | 21 | 165 | 127 | 23 | 116 | 24 | 19 | 42 | 8 | 20 | 12 |
| Investments | 138 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 361 | 424 | 534 | 534 | 349 | 354 | 275 | 256 | 223 | 215 | 217 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 51 | 281 | 208 | 34 | 10 | 46 | 7 | 10 | 5 | 2 | 9 | 49 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 391 | 235 | 370 | 420 | 397 | 309 | 247 | 203 | 170 | 138 | 118 | 135 |
| Share Capital | 22 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 |
| Reserves & Surplus | 368 | 215 | 350 | 400 | 377 | 290 | 227 | 183 | 150 | 119 | 99 | 116 |
ASTEC Cash Flow Statement — Operating, Investing & Financing
Astec Lifesciences operating cash flow ₹-8 Cr, investing ₹-15 Cr, financing ₹24 Cr, net cash flow ₹0 Cr (2025).
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -8 | 10 | 75 | 24 | -8 | 168 | 15 | 65 | 19 | -13 | 8 |
| Investing Activities | -15 | -135 | -113 | -104 | -73 | -74 | -53 | -49 | -18 | -17 | -19 |
| Financing Activities | 24 | 125 | 38 | 81 | 81 | -95 | 37 | -18 | -1 | 31 | 12 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 | 1 | 2 | 0 |